New Zealand markets close in 4 hours

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
55.53-1.05 (-1.86%)
At close: 04:00PM EST
55.55 +0.02 (+0.04%)
After hours: 06:42PM EST
Currency in USD

Valuation measures

Market cap (intra-day) 5173.43B
Enterprise value 3198.19B
Trailing P/E 101.95
Forward P/E 117.30
PEG ratio (5-yr expected) 11.01
Price/sales (ttm)4.71
Price/book (mrq)4.41
Enterprise value/revenue 36.04
Enterprise value/EBITDA 725.01

Trading information

Stock price history

Beta (5Y monthly) 0.15
52-week change 36.88%
S&P500 52-week change 326.87%
52-week high 364.21
52-week low 346.48
50-day moving average 360.11
200-day moving average 356.16

Share statistics

Avg vol (3-month) 35.2M
Avg vol (10-day) 36.79M
Shares outstanding 53.1B
Implied shares outstanding 6N/A
Float 82.98B
% held by insiders 10.05%
% held by institutions 117.43%
Shares short (14 Nov 2021) 46.96M
Short ratio (14 Nov 2021) 41.71
Short % of float (14 Nov 2021) 4N/A
Short % of shares outstanding (14 Nov 2021) 40.22%
Shares short (prior month 14 Oct 2021) 47.14M

Dividends & splits

Forward annual dividend rate 41.4
Forward annual dividend yield 42.47%
Trailing annual dividend rate 33.70
Trailing annual dividend yield 36.54%
5-year average dividend yield 43.45
Payout ratio 4252.25%
Dividend date 312 Sep 2021
Ex-dividend date 411 Aug 2021
Last split factor 22:1
Last split date 326 Jul 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin 4.48%
Operating margin (ttm)9.80%

Management effectiveness

Return on assets (ttm)2.35%
Return on equity (ttm)5.48%

Income statement

Revenue (ttm)32.82B
Revenue per share (ttm)12.08
Quarterly revenue growth (yoy)50.00%
Gross profit (ttm)21.37B
Net income avi to common (ttm)1.47B
Diluted EPS (ttm)0.54
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.15B
Total cash per share (mrq)2.39
Total debt (mrq)34.39B
Total debt/equity (mrq)86.16
Current ratio (mrq)1.13
Book value per share (mrq)13.28

Cash flow statement

Operating cash flow (ttm)6.34B
Levered free cash flow (ttm)-1.39B